Patent · US Active

Spiropiperidines for use as tryptase inhibitors

US8536189B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Michael John Costanzo · Bonney Lake, US
Stephen C. Yabut · North Wales, US
Brett A. Tounge · Blue Bell, US
Bruce E. Maryanoff · Robinson Township, US
Han-Cheng Zhang · Lansdale, US

Key dates

Filing date	Mar 1, 2012
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Mar 1, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to a compound of Formula (I):or a form thereof, wherein X1, X2, X3, X4, R1, R2 and R3 are as defined herein, useful as tryptase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.